cin-102
ishares biotechnology,spdr s&p biotech,cinrx pharma
['dompe', '$ibb', '$xbi']
cindome pharma's deudomperidone (cin-102) receives positive reception with latest data presented at 2023 digestive disease week conference more info: $xbi $ibb $xph $pph 
BioPharma/Biotech Intel.  Daily $XBI $XPH Market Movers

Database: https://t.co/IBOqbSoYuc
Clinical trial tools: https://t.co/A77u9Q84Dc  http://globalclinicalt